Related Experiment Video
Updated: Jul 26, 2026
14:58
High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions
Published on: March 5, 2022
4.5K
High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized
Jeremy W Prokop1,2, Nicholas L Hartog1,3, Dave Chesla4,5
1Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI, United States.
Frontiers in Immunology
|August 2, 2021
Summary
High-density blood RNA sequencing reveals distinct immune signatures in COVID-19 patients, differentiating severity and treatment responses. This transcriptomic analysis offers insights into immune activation and secondary infections for personalized precision treatment.
Area of Science:
- Immunology
- Genomics
- Infectious Diseases
Background:
- The immune response to COVID-19 is highly variable, impacting clinical outcomes.
- Understanding this variability requires analysis of accessible biological materials like blood.
Purpose of the Study:
- To investigate host blood RNA profiles in hospitalized COVID-19 patients using high-density transcriptomics and bioinformatics.
- To uncover mechanistic insights into the heterogeneous immune responses observed in COVID-19.
Main Methods:
- Enrolled 36 hospitalized COVID-19 patients and 15 controls, collecting 74 blood samples.
- Performed high-density RNA sequencing (>160 million reads/sample) on blood PAXgene tubes.
- Utilized advanced multidimensional bioinformatics for RNA analysis.
Main Results:
- Identified 770 significantly altered genes in COVID-19 patients, linked to antiviral defense, cell cycle, and interferon signaling.
- Observed activation of neutrophil-related genes and decreased lymphocyte expression, alongside NETs.
- Found that therapies like convalescent serum and dexamethasone modulated COVID-19 expression signatures.
- Severely ill patients exhibited unique gene patterns, dysregulated innate immunity, and organ damage.
Conclusions:
- High-density transcriptomics provides shared and individualized gene expression signatures for COVID-19.
- Whole blood transcriptomics offers patient-level insights into immune activation, repertoire, and secondary infections.
- This approach can guide precision treatment strategies for COVID-19 patients.
